Regulatory Show all
April 2 | 2019

Communique from extraordinary general meeting of 2cureX AB (publ)

Read more
April 2 | 2019

Kommuniké från extra bolagsstämma i 2cureX AB (publ)

Read more
March 28 | 2019

2cureX receives Notice of Allowance from the United States Patent Office

Read more
March 28 | 2019

2cureX erhåller Notice of Allowance från det amerikanska patentverket

Read more
March 14 | 2019

Notice of extraordinary general meeting in 2cureX AB (publ)

Read more
March 14 | 2019

Kallelse till extra bolagsstämma i 2cureX AB (publ)

Read more
March 12 | 2019

2cureX utvidgar verksamheten till förebyggande cancermedicin

Read more
March 12 | 2019

2cureX expands its activities to preventive cancer medicine

Read more
March 1 | 2019

2cureX offentliggör bokslutskommuniké för räkenskapsåret 2018

Read more
March 1 | 2019

2cureX publishes year-end report for the fiscal year 2018

Read more
February 20 | 2019

Correction – Lack of reference to MAR – 2cureX meddelar positiva resultat från pågående klinisk studie med kraftigt förbehandlade kolorektalcancerpatienter

Read more
February 20 | 2019

Correction – Lack of reference to MAR – 2cureX reports positive results from an ongoing clinical trial in heavily pre-treated colorectal cancer patients

Read more
January 16 | 2019

2cureX strengthens the organisation via the recruitment of a CFO

Read more
January 16 | 2019

2cureX stärker organisationen genom rekrytering av CFO

Read more
December 10 | 2018

2cureX accelererar lanseringen av IndiTreat®

Read more
December 10 | 2018

2cureX is accelerating the launch of IndiTreat®

Read more
November 23 | 2018

2cureX AB publishes interim report for January – September 2018

Read more
November 23 | 2018

2cureX AB offentliggör delårsrapport för januari – september 2018

Read more